Supplier News

Through a license agreement with the Broad Institute, Charles River Laboratories will now be offering gene-editing engineering technology.

The company opened a new facility in Dublin for its cell performance technology.

Vetter’s Ravensburg data processing center received certification from a German industrial testing organization, certifying that the company’s customer and process data are protected.

STEERLife and the University of Mississippi will collaborate on fractional lobe processing research.

Neovacs acquired Amegabiotech’s Interferon Alpha manufacturing license for the manufacture of its lead therapeutic candidate.

The company expanded its commercial packaging facility in response to a growing demand for pediatric drugs.

Avecia is adding drug substance capacity at its Milford, MA manufacturing site.

The new Boston laboratory offers advanced analytical testing services.

Dedicated facility will address enhanced regulation of metals and impurities in pharmaceuticals.

The company invested more than €250 in production in China.

The company announce its plans to invest $7 million in the expansion of the Westborough, MA facility.

Interactive Coding Equipment has produced a detailed guide to help pharmaceutical manufacturers make informed choices in the selection of suitable coding equipment for their applications.

TraceLink launched the EU-hosted early access program to reduce the time, cost, and risk of achieving regulatory compliance for global requirements.

GENCO, a FedEx Company, introduces a multi-tenant warehouse model in Milton, Ontario, and Memphis, Tennessee.

IDT Biologika will provide fill/finish services of live-vectored virus products in clinical development through licensure.

Catalent invests $34 million to add a 2 x 2000-L single-use bioreactor system and laboratory space in Madison, WI.

Horizon announces new bioproduction outlicense deal with an unnamed partner for a minimum value of £500,000.

Prefilled syringes for commercial supply of the etanercept biosimilar will be produced at Catalent’s Brussels facility in Belgium.

A €15-million investment will be made over 2014-2016 in a biotech facility located in Tres Cantos, Spain

Recipharm announced that it has invested 5 million SEK in a new GLP bioanalysis laboratory in Uppsala.

The companies will collaborate the manufacture of personalized cancer vaccines.

The company invested more than CHF 100 million in a new Delaware manufacturing plant.

Marken announced the opening of a new depot and logistics operations center in Argentina.

The company announced that it will build a new manufacturing facility at the GMR Aerospace Park at the Rajiv Gandhi International Airport in India.

Constantia Flexibles acquired a flexible packaging business from Lamp San Prospero SPA.

The company invested in a new cGMP facility located in Berlin, Germany.

PaizaBio will add aseptic injectable production capacity in Hangzhou, China.

Onset expanded its product line for pharmaceutical cold-chain management with the launch two new products.